Status:
RECRUITING
Home-based Heat Therapy for Type 2 Diabetes
Lead Sponsor:
Montreal Heart Institute
Conditions:
Diabetes Mellitus, Type 2
Heat Exposure
Eligibility:
All Genders
45-75 years
Phase:
NA
Brief Summary
Insulin resistance and hyperglycemia predispose individuals with type 2 diabetes mellitus (T2DM) to endothelial dysfunction and a greater risk of cardiovascular diseases (CVD). Increased CVD risk in i...
Eligibility Criteria
Inclusion
- Age 45-75 years
- Diagnosis of type 2 diabetes mellitus ≥1 year
- Stable medication ≥12 weeks
Exclusion
- Class 3 obesity
- Hypertension not controled by medication
- Diagnosis of cardiac, renal and/or pulmonary disease
- Diagnosis of severe neuropathy and/or retinopathy
- Insulin therapy
- Fasting plasma triglycerides \>5.0 mmol/L
- Fasting total cholesterol \>7 mmol/l
Key Trial Info
Start Date :
February 18 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT05269589
Start Date
February 18 2022
End Date
December 1 2026
Last Update
December 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre ÉPIC, Montreal Heart Institute
Montreal, Quebec, Canada, H1T1N6